CHRS Historical Earnings image   This CHRS historical earnings page last updated 3/15/2024
CHRS Historical Revenue
PeriodHistorical Earnings DateGAAP
Q4 20233/13/20240.09B
Q3 202311/6/20230.07B
Q2 20238/2/20230.06B
Q1 20235/8/20230.03B
Q4 20223/6/20230.05B
Q3 202211/8/20220.05B
Q2 20228/4/20220.06B
Q1 20225/5/20220.06B
Q4 20212/17/20220.07B
Q3 202111/8/20210.08B
Q2 20218/5/20210.09B
Q1 20215/6/20210.08B
Q4 20202/24/20210.11B
Q3 202011/5/20200.11B
Q2 20208/6/20200.14B
Q1 20205/7/20200.12B
Q4 20192/27/20200.12B
Q3 201911/6/20190.11B
Q2 20198/1/20190.08B
Q1 20195/9/20190.04B
Q4 20182/28/2019NA
Q3 201811/8/2018NA
Q2 20188/8/2018NA
Q1 20185/10/2018NA
Q4 20173/8/2018NA
Q3 201711/6/2017NA
Q2 20178/7/20171.40M
Q1 20175/8/2017161000
Q4 20163/13/2017844000
Q3 201611/9/2016162.84M
Q2 20168/9/201614.07M
Q1 20165/9/201612.36M
Q4 20152/29/201610.20M
Q3 201511/9/20157.17M
Q2 20158/10/20156.87M
Q1 20155/11/20155.81M
Q4 20143/23/20156.49M
Q3 201412/15/201416.05M
CHRS Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q4 20233/13/2024-0.620
Q3 202311/6/2023-0.270
Q2 20238/2/2023-0.380
Q1 20235/8/2023-0.750
Q4 20223/6/2023-0.600
Q3 202211/8/2022-0.960
Q2 20228/4/2022-0.470
Q1 20225/5/2022-1.000
Q4 20212/17/2022-0.460
Q3 202111/8/2021-0.340
Q2 20218/5/2021-0.360
Q1 20215/6/20210.010
Q4 20202/24/20210.230
Q3 202011/5/20200.470
Q2 20208/6/20200.810
Q1 20205/7/20200.480
Q4 20192/27/20200.530
Q3 201911/6/20190.630
Q2 20198/1/20190.320
Q1 20195/9/2019-0.290
Q4 20182/28/2019-0.92
Q3 201811/8/2018-0.87
Q2 20188/8/2018-0.68
Q1 20185/10/2018-0.74
Q4 20173/8/2018-0.84
Q3 201711/6/2017-1.09
Q2 20178/7/2017-1.08
Q1 20175/8/2017-1.54
Q4 20163/13/2017-1.71
Q3 201611/9/20161.67
Q2 20168/9/2016-1.72
Q1 20165/9/2016-1.67
Q4 20152/29/2016-1.35
Q3 201511/9/2015-1.86
Q2 20158/10/2015-1.56
Q1 20155/11/2015-1.22
Q4 20143/23/2015-1.47
Q3 201412/15/2014-1.79
Quotes delayed 20 minutes

Email EnvelopeFree CHRS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Coherus BioSciences (CHRS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CI Historical Earnings
CINC Historical Earnings
CKPT Historical Earnings
CLBS Historical Earnings
CLDX Historical Earnings
CLNN Historical Earnings
CLOV Historical Earnings
CLPT Historical Earnings
CLRB Historical Earnings
CLSD Historical Earnings
What was the record high CHRS historical earnings result?
In terms of earnings or revenue, what is the best CHRS historical earnings result that Coherus BioSciences has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CHRS historical earnings result was set in Q3 2016, when Coherus BioSciences posted results of 1.67/share. The most successful revenue quarter within our data set was Q3 2016 when Coherus BioSciences reported revenue of 162.84M.

What was the lowest Coherus BioSciences historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CHRS has reported, and when?

✔️Accepted answer: Within our data set, the lowest CHRS historical earnings result was set in Q3 2015, when Coherus BioSciences posted results of -1.86/share. The smallest revenue quarter within our data set was Q4 2018 when Coherus BioSciences reported revenue of NA.

On this page we presented the CHRS historical earnings date information for Coherus BioSciences. Reviewing that CHRS Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2016, when CHRS posted adjusted EPS of 1.67/share. Meanwhile the lowest CHRS historical earnings result was in Q3 2015, when CHRS posted adjusted EPS of -1.86/share. Moving to Coherus BioSciencess historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2016 when CHRS reported 162.84M in revenue, while the smallest revenue quarter was Q4 2018 when CHRS reported NA in revenue.

For self directed investors doing their due diligence on CHRS or any other given stock, their research can benefit from looking into all of the Coherus BioSciences historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you to make it more convenient for investors to look into Coherus BioSciences historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CHRS. Thanks for visiting, and the next time you need to research CHRS historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: HPT YTD Return, Institutional Holders of IMBI, Funds Holding KORS.


CHRS Historical Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.